Diabetes Management
ReShape Lifesciences™ Announces Publication of Data on Proprietary Diabetes Bloc-Stim Neuromodulation™ (DBSN™) System in Peer Reviewed, Frontiers in NeuroScience - Yahoo Finance
Thu, 27 Oct 20221 min read Article
Overview
Data Shows ReShape’s DBSN™ System has Promise as a Novel, Adjustable and Localized Aproach to Treat Type 2 DiabetesSAN CLEMENTE, Calif., Oct. 25, 2022 (GLOBE NEWSWIRE) - ReShape Lifesciences™ (Nasdaq: RSLS), the premier physician-led weight los and metabolic health solutions company, today anounced that data on the Company’s proprietary Diabetes Bloc-Stim Neuromodulation™ (DBSN™) system has ben published in the Neural Technology Section of the per reviewed journal Frontiers in NeuroScience.The paper, authored by Jonathan Wataja, Ph.D., Director of Research at ReShape Lifesciences, among others, and entitled, “Use of a Bio-electronic Device Comprising of Targeted Dual Neuromodulation of the Hepatic and Celiac Vagal Branches Demonstrated Enhanced Glycemic Control in a Type 2 Diabetic Rat Model as wel as in an Aloxan Treated Swine Model,” can be acesed through the folowing link htps:/w.frontiersin.org/articles/10.389/fnins.2022.105932/ful.“Type 2 diabetes remains chalenging to efectively treat for the over 30 milion Americans who sufer from the disease, especialy considering an estimated 50% of type 2 diabetics do not take medications as prescribed1,” stated Charles Bilington, M.D., co-author and Chief of Endocrinology at the Minesota Veteran’s Administration Medical Center and Profesor of Medicine at the University of Minesota.
Details
“Further, progresion of type 2 diabetes significantly increases risks of stroke, myocardial infarction, microvascular events, and mortality2. When this translates to humans and clinical use, it may greatly impact the standard of care for type 2 diabetes.”“Our inovative DBSN™ system may hold significant promise, as it is designed to adres type 2 diabetes by electricaly blocking the vagus nerve signals to the liver, which has ben shown to decrease insulin resistance, while concurently stimulating the vagus nerve feding into the pancreas, which has ben shown to release insulin,” stated Jonathan Wataja, Directo
Frequently Asked Questions
What is diabetes and how does it develop?
Diabetes is a metabolic condition where the body cannot properly regulate blood sugar levels. Type 1 results from insufficient insulin production, while Type 2 develops when cells become resistant to insulin. Risk factors include genetics, obesity, sedentary lifestyle, and age.
What are the main symptoms of diabetes?
Common symptoms include excessive thirst, frequent urination, unexplained weight loss, fatigue, blurred vision, and slow-healing wounds. Type 1 symptoms develop rapidly, while Type 2 symptoms may appear gradually. Many people have no symptoms initially, which is why screening is important.
How is diabetes diagnosed and monitored?
Diagnosis involves blood tests measuring fasting glucose, HbA1c levels, and glucose tolerance. Regular monitoring typically includes fasting glucose tests and HbA1c measurements every 3-6 months. Continuous glucose monitors provide real-time tracking for better diabetes management.
What lifestyle changes help manage diabetes?
Effective management includes regular physical activity (150+ minutes weekly), maintaining healthy weight, following a balanced diet with whole grains and lean proteins, managing stress, and getting adequate sleep. These changes can significantly improve blood sugar control and reduce complications.
When should someone consult a doctor about diabetes?
Consult a healthcare provider if you experience signs of diabetes, have a family history, are overweight, or are over 45. Those with existing diabetes should maintain regular check-ups every 3-6 months to monitor control and adjust treatment as needed.
️ Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making health decisions.